Genomic Health (GHDX) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Total operating expenses: 262.05M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Total operating expenses: 262.05M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $74.03 million.
GUIDANCE:
Genomic Health sees FY2016 revenue of $320-335 million, versus the consensus of $328.8 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
